Exclusive Content:

Salaries for finance sector master’s graduates surge ahead

"Salaries for Finance Graduates Surge, Gender Pay Gap...

Changes in Middle-Class Spending After the Pandemic

Middle-Class Spending Trends Post-Pandemic: A Look at the...

Arizona Budget Includes Accounting Maneuvers and ESA Changes, But...

Arizona Lawmakers Pass Budget After Hours of Negotiations Arizona...

Organto Issues Bi-Weekly Update Regarding Annual Financial Statements Filing

Organto Issues Bi-Weekly Update Regarding Annual Financial Statements Filing

Organto Foods Inc. Provides Update on Management Cease Trade Order for Late Filings of Annual Financial Statements

Organto Foods Inc., a prominent provider of organic and non-GMO fruit and vegetable products, is currently under a management cease trade order (MCTO) due to the late filing of its annual financial statements for the year ended December 31, 2023. The British Columbia Securities Commission granted the MCTO on May 1, 2024, prohibiting the Co-Chief Executive Officers and the Chief Financial Officer from trading in securities of the company until the Annual Filings are submitted and the MCTO is revoked.

The company is diligently working with its accounting team to finalize the Annual Filings by June 28, 2024. In the meantime, Organto plans to comply with alternative information guidelines and issue bi-weekly default status reports. Despite the delay in filing, there have been no material changes or defaults by the company, and it is not subject to any insolvency proceedings.

Organto is known for its commitment to sustainable business practices and providing organic and non-GMO products to health-conscious consumers globally. The company’s business model focuses on environmental responsibility and supporting the communities where it operates.

Investors and stakeholders can expect further updates as Organto works towards resolving the MCTO and submitting the required financial statements. For more information, interested parties can contact John Rathwell, Senior Vice President of Investor Relations & Corporate Development, at 647 629 0018 or info@organto.com.

This news story highlights the challenges faced by Organto Foods Inc. and its dedication to transparency and compliance in the financial reporting process. Stay tuned for more updates on this developing situation.

Latest

Salaries for finance sector master’s graduates surge ahead

"Salaries for Finance Graduates Surge, Gender Pay Gap...

Changes in Middle-Class Spending After the Pandemic

Middle-Class Spending Trends Post-Pandemic: A Look at the...

Arizona Budget Includes Accounting Maneuvers and ESA Changes, But No Tax Hikes

Arizona Lawmakers Pass Budget After Hours of Negotiations Arizona...

William Donaldson, former SEC chief known for strengthening oversight, passes away at 93

William Donaldson, Former SEC Chairman Who Overhauled Oversight...

Newsletter

Don't miss

HKA expands forensic accounting and commercial damages practice with three new experts

HKA Welcomes Three Experts to Forensic Accounting and...

Delta Air Lines CEO Challenges the Economic Tactics of Budget Airlines

Delta Air Lines CEO Critiques Low-Cost Carriers Amid...

Salaries for finance sector master’s graduates surge ahead

"Salaries for Finance Graduates Surge, Gender Pay Gap Narrows: FT Ranking 2024" The latest Financial Times ranking of masters in finance programs has revealed...

Tesla and Nvidia Stocks: Why a $2,600 Price Target...

Comparing Nvidia's Challenges to Tesla's Bold Projections: A Reality Check The Battle of Titans: Nvidia vs. Tesla - A Clash of Projections In the world...

Approval Granted for Study on Equity Research Biosergen: BSG005...

Update on BSG005 Phase Ib Study: CDSCO grants import license Biosergen and Alkem Laboratories have received permission to test BSG005 as a rescue therapy...